Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3809403
Max Phase: Preclinical
Molecular Formula: C25H26O6
Molecular Weight: 422.48
Molecule Type: Small molecule
Associated Items:
ID: ALA3809403
Max Phase: Preclinical
Molecular Formula: C25H26O6
Molecular Weight: 422.48
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)=CCc1cc(-c2coc3cc(O)c(CC=C(C)C)c(O)c3c2=O)cc(O)c1O
Standard InChI: InChI=1S/C25H26O6/c1-13(2)5-7-15-9-16(10-20(27)23(15)28)18-12-31-21-11-19(26)17(8-6-14(3)4)24(29)22(21)25(18)30/h5-6,9-12,26-29H,7-8H2,1-4H3
Standard InChI Key: QNLGNISMYMFVHP-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 422.48 | Molecular Weight (Monoisotopic): 422.1729 | AlogP: 5.30 | #Rotatable Bonds: 5 |
Polar Surface Area: 111.13 | Molecular Species: ACID | HBA: 6 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 6.36 | CX Basic pKa: | CX LogP: 6.23 | CX LogD: 5.06 |
Aromatic Rings: 3 | Heavy Atoms: 31 | QED Weighted: 0.33 | Np Likeness Score: 1.81 |
1. Ji S, Li Z, Song W, Wang Y, Liang W, Li K, Tang S, Wang Q, Qiao X, Zhou D, Yu S, Ye M.. (2016) Bioactive Constituents of Glycyrrhiza uralensis (Licorice): Discovery of the Effective Components of a Traditional Herbal Medicine., 79 (2): [PMID:26841168] [10.1021/acs.jnatprod.5b00877] |
2. Kuang Y, Li B, Fan J, Qiao X, Ye M.. (2018) Antitussive and expectorant activities of licorice and its major compounds., 26 (1): [PMID:29224994] [10.1016/j.bmc.2017.11.046] |
3. Fan JR, Kuang Y, Dong ZY, Yi Y, Zhou YX, Li B, Qiao X, Ye M.. (2020) Prenylated Phenolic Compounds from the Aerial Parts of Glycyrrhiza uralensis as PTP1B and α-Glucosidase Inhibitors., 83 (4): [PMID:32196343] [10.1021/acs.jnatprod.9b00262] |
4. Sun S, Dibwe DF, Kim MJ, Omar AM, Phan ND, Fujino H, Pongterdsak N, Chaithatwatthana K, Phrutivorapongkul A, Awale S.. (2021) A new anti-austerity agent, 4'-O-methylgrynullarin from Derris scandens induces PANC-1 human pancreatic cancer cell death under nutrition starvation via inhibition of Akt/mTOR pathway., 40 [PMID:33753259] [10.1016/j.bmcl.2021.127967] |
Source(1):